Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2469826, 11 pages
https://doi.org/10.1155/2017/2469826
Research Article

Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin in Pig against Korean Local Isolates of Actinobacillus pleuropneumoniae

Veterinary Drugs & Biologics Division, Animal and Plant Quarantine Agency (QIA), 177 Hyeoksin 8-ro, Gimcheon-si, Gyeongsangbuk-do 39660, Republic of Korea

Correspondence should be addressed to JeongWoo Kang; rk.aerok@hcajih and Kwang-jick Lee; rk.aerok@jwkeel

Received 19 December 2016; Revised 24 February 2017; Accepted 6 March 2017; Published 6 April 2017

Academic Editor: Ronald E. Baynes

Copyright © 2017 Md. Akil Hossain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Shojaee AliAbadi and P. Lees, “Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate,” Journal of Veterinary Pharmacology and Therapeutics, vol. 25, no. 3, pp. 161–174, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. S. A. Brown, “Fluoroquinolones in animal health,” Journal of Veterinary Pharmacology and Therapeutics, vol. 19, no. 1, pp. 1–14, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Vilalta, H. Giboin, M. Schneider, F. El Garch, and L. Fraile, “Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin in the treatment of Haemophilus parasuis and Actinobacillus pleuropneumoniae infections in nursery and fattener pigs using Monte Carlo simulations,” Journal of Veterinary Pharmacology and Therapeutics, vol. 37, no. 6, pp. 542–549, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Gottschalk and D. J. Taylor, “Actinobacillus pleuropneumoniae,” in Diseases of Swine, E. S. Barbara, J. Z. Jeffrey, D. A. Sylvie, and J. T. David, Eds., pp. 343–355, Blackwell Publishing, Ames, Iowa, USA, 9th edition, 2006. View at Google Scholar
  5. J. I. MacInnes and S. Rosendal, “Prevention and control of Actinobacillus (Haemophilus) pleuropneumoniae infection in swine: a review,” Canadian Veterinary Journal, vol. 29, no. 7, pp. 572–574, 1988. View at Google Scholar · View at Scopus
  6. H. Vigre, Ø. Angen, K. Barfod, D. T. Lavritsen, and V. Sørensen, “Transmission of Actinobacillus pleuropneumoniae in pigs under field-like conditions: emphasis on tonsillar colonisation and passively acquired colostral antibodies,” Veterinary Microbiology, vol. 89, no. 2-3, pp. 151–159, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. D. T. Lavritsen, K. Barfod, Ø. Angen, and V. Sørensen, “Carrier animals in a Danish high-health multiplying herd recently infected with Actinobacillus pleuropneumoniae serotype 2,” in Proceedings of the 17th International Pig Veterinary Society Congress, vol. 1, p. 183, Ames, Iowa USA, June 2002.
  8. M. Vanni, M. Merenda, G. Barigazzi et al., “Antimicrobial resistance of Actinobacillus pleuropneumoniae isolated from swine,” Veterinary Microbiology, vol. 156, no. 1-2, pp. 172–177, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Gouvea, F. F. dos Santos, M. H. C. de Aquino, and A. V. L. Pereira, “Fluoroquinolones in industrial poultry production, bacterial resistance and food residues: a review,” Brazilian Journal of Poultry Science, vol. 17, no. 1, pp. 1–10, 2015. View at Google Scholar
  10. Animal & Veterinary, Extralabel Use and Antimicrobials, Food and Drug Administration, Silver Spring, Md, USA, 2014.
  11. A. Wasley and V. Parsons, Banned in America, Soaring Use in Britain: The Poultry Farm Drugs That Put Human Lives at Risk, The Bureau of Investigative Journalism, London, UK, 2016.
  12. T. Trouchon and S. Lefebvre, “A review of enrofloxacin for veterinary use,” Open Journal of Veterinary Medicine, vol. 6, no. 2, pp. 40–58, 2016. View at Publisher · View at Google Scholar
  13. E. E. Baroni, C. Rodríguez, G. Crudeli et al., “Pharmacokinetics of marbofloxacin, after single intravenous administrations, in buffaloes calves,” Italian Journal of Animal Science, vol. 6, supplement 2, pp. 838–841, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Elias, J.-S. Lee, M.-H. Hwang et al., “Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of orbifloxacin in Korean Hanwoo cattle,” Journal of Veterinary Pharmacology and Therapeutics, vol. 32, no. 3, pp. 219–228, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Regnier, D. Concordet, M. Schneider, B. Boisramé, and P.-L. Toutain, “Population pharmacokinetics of marbofloxacin in aqueous humor after intravenous administration in dogs,” American Journal of Veterinary Research, vol. 64, no. 7, pp. 889–893, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Shem-Tov, G. Ziv, A. Glickman, and A. Saran, “Pharmacokinetics and penetration of marbofloxacin from blood into the milk of cows and ewes,” Zentralblatt für Veterinärmedizin Reihe A, vol. 44, no. 9-10, pp. 511–519, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Waxman, C. Rodríguez, F. González, M. L. De Vicente, M. I. San Andrés, and M. D. San Andrés, “Pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in adult goats,” Journal of Veterinary Pharmacology and Therapeutics, vol. 24, no. 6, pp. 375–378, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Schneider, M. Vallé, F. Woehrlé, and B. Boisramé, “Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains,” Journal of Dairy Science, vol. 87, no. 1, pp. 202–211, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. G. A. Albarellos, V. E. Kreil, and M. F. Landoni, “Pharmacokinetics of ciproloxacin after single intravenous and repeat oral administration to cats,” Journal of Veterinary Pharmacology and Therapeutics, vol. 27, no. 3, pp. 155–162, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. P. K. Sidhu, M. F. Landoni, F. S. Aliabadi, and P. Lees, “PK-PD integration and modeling of marbofloxacin in sheep,” Research in Veterinary Science, vol. 88, no. 1, pp. 134–141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Heinen, “Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration,” Journal of Veterinary Pharmacology and Therapeutics, vol. 25, no. 1, pp. 1–5, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Schneider, A. Paulin, F. Dron, and F. Woehrlé, “Pharmacokinetics of marbofloxacin in pigs after intravenous and intramuscular administration of a single dose of 8 mg/kg: dose proportionality, influence of the age of the animals and urinary elimination,” Journal of Veterinary Pharmacology and Therapeutics, vol. 37, no. 6, pp. 523–530, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Ding, Y. Li, Z. Chen, M. Rizwan-Ul-Haq, and Z. Zeng, “Plasma and tissue cage fluid pharmacokinetics of marbofloxacin after intravenous, intramuscular, and oral single-dose application in pigs,” Journal of Veterinary Pharmacology and Therapeutics, vol. 33, no. 5, pp. 507–510, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. International Conference on Harmonization (ICH), Validation of Analytical Procedures d PA/PH/OMCL (05) 47 DEF, OMCL Network/EDQM of the Council of Europe, 2005.
  25. P. Marín, L. F. Álamo, E. Escudero, E. Fernández-Varón, V. Hernandis, and C. M. Cárceles, “Pharmacokinetics of marbofloxacin in rabbit after intravenous, intramuscular, and subcutaneous administration,” Research in Veterinary Science, vol. 94, no. 3, pp. 698–700, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Gloede, C. Scheerans, H. Derendorf, and C. Kloft, “In vitro pharmacodynamic models to determine the effect of antibacterial drugs,” The Journal of Antimicrobial Chemotherapy, vol. 65, no. 2, pp. 186–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. P. L. Toutain and P. Lees, “Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine,” Journal of Veterinary Pharmacology and Therapeutics, vol. 27, no. 6, pp. 467–477, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. M. E. Klepser, E. J. Ernst, C. R. Petzold, P. Rhomberg, and G. V. Doern, “Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 3, pp. 673–678, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. K. J. Madaras-Kelly and T. A. Demasters, “In vitro characterization of fluoroquinolone concentration/MIC antimicrobial activity and resistance while simulating clinical pharmacokinetics of levofloxacin, ofloxacin, or ciprofloxacin against Streptococcus pneumoniae,” Diagnostic Microbiology and Infectious Disease, vol. 37, no. 4, pp. 253–260, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. ICH guidelines Q1A (R2), Stability Testing of New Drug Substances and Products, International Conference on Harmonization, Geneva, Switzerland, 2003.
  31. ICH guidelines Q2 (R1), Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonization, Geneva, Switzerland, 2005.
  32. CLSI (Clinical and Laboratory Standards Institute), Performance Standards for Antimicrobial Susceptibility Testing, 17th Informational supplement, Document M100–S17, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2007.
  33. M. Carretero, C. Rodríguez, M. I. San Andrés et al., “Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration,” Equine Veterinary Journal, vol. 34, no. 4, pp. 360–365, 2002. View at Google Scholar · View at Scopus
  34. S. Yohannes, E. G. Awji, S.-J. Lee, and S.-C. Park, “Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin after intravenous and intramuscular administration in beagle dogs,” Xenobiotica, vol. 45, no. 3, pp. 264–269, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Belew, J.-Y. Kim, M. A. Hossain et al., “Pharmacokinetics of marbofloxacin after intravenous and intramuscular administration in Hanwoo, Korean native cattle,” Journal of Veterinary Medical Science, vol. 77, no. 3, pp. 327–329, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. Guidance for Industry, Bioanalytical Method Validation, Food and Drug Administration, Maryland, Md, USA, 2013.
  37. Standard Format and Guidance for AOAC Standard Method Performance Requirement, AOAC International, Maryland, Md, USA, 2011.
  38. R. Laraje, A. Talmi, R. Bounaga, M. Bengoumi, A. El Hraiki, and M. Laurentie, “Comparative pharmacokinetics of marbofloxacin after a single intramuscular administration at two dosages to camels (Camelus dromedarius),” Journal of Veterinary Pharmacology and Therapeutics, vol. 29, no. 3, pp. 229–231, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Ismail and Y. A. El-Kattan, “Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves,” Research in Veterinary Science, vol. 82, no. 3, pp. 398–404, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Marín, O. R. Lai, P. Laricchiuta et al., “Pharmacokinetics of marbofloxacin after a single oral dose to loggerhead sea turtles (Caretta caretta),” Research in Veterinary Science, vol. 87, no. 2, pp. 284–286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Jian, X. Xia, H. Rui-Juan et al., “In vitro Dynamic Pharmacokinetic/Pharamcodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis,” BMC Veterinary Research, vol. 11, article 293, 2015. View at Publisher · View at Google Scholar
  42. B. Zhang, X. Gu, X. Li et al., “Pharmacokinetics and ex-vivo pharmacodynamics of cefquinome against Klebsiella pneumonia in healthy dogs,” Journal of Veterinary Pharmacology and Therapeutics, vol. 37, no. 4, pp. 367–373, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Winther, K. E. Baptiste, and C. Friis, “Antimicrobial disposition in pulmonary epithelial lining fluid of horses, part III. Cefquinome,” Journal of Veterinary Pharmacology and Therapeutics, vol. 34, no. 5, pp. 482–486, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. A. M. Haritova, N. V. Rusenova, P. R. Parvanov, L. D. Lashev, and J. Fink-Gremmels, “Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 11, pp. 3779–3785, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. P. L. Toutain, J. R. E. Del Castillo, and A. Bousquet-Mélou, “The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics,” Research in Veterinary Science, vol. 73, no. 2, pp. 105–114, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Martinez, P. McDermott, and R. Walker, “Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals,” The Veterinary Journal, vol. 172, no. 1, pp. 10–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Spreng, J. Deleforge, V. Thomas, B. Boisramé, and H. Drugeon, “Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates,” Journal of Veterinary Pharmacology and Therapeutics, vol. 18, no. 4, pp. 284–289, 1995. View at Publisher · View at Google Scholar · View at Scopus
  48. H. B. Drugeon, V. Thomas, L. Guillardeau, and E. Thomas, “Antibacterial activity of marbofloxacin against bovine respiratory isolates,” Journal of Veterinary Pharmacology and Therapeutics, vol. 20, pp. 138–139, 1997. View at Google Scholar